Ohio State University Comprehensive Cancer Center-James Cancer Hospital & Solove Research Institute shared on LinkedIn:
“Eric Miller, MD, PhD, is leading an exciting international clinical trial focused on total ablative therapy as an addition to treatment for patients with limited metastatic colorectal cancer.
Alliance for Clinical Trials in Oncology shares more details about the ERASur Trial, which recently expanded participant enrollment outside the U.S: ERASur Colorectal Cancer Trial Reaches One-Third Patient Accrual Milestone.”
Other articles about colorectal cancer on OncoDaily.